Heinz-Peter Schultheiss

6PUBLICATIONS
67CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 23, 2026
Immunoadsorption in dilated cardiomyopathy: the IASO-DCM trial.

Stephan B Felix, Michael Böhm, Rüdiger C Braun-Dullaeus

|May 31, 2025
Targeting CD8+ T cells in cardiovascular diseases: current options and therapeutic perspectives.

Rida Al-Rifai, Vincent Duval, Icia Santos-Zas

|Nov 09, 2023
Endomyocardial biopsy in fulminant myocarditis: need for early and accurate diagnosis to improve the outcome.

Heinz-Peter Schultheiss, Felicitas Escher

|Jul 13, 2022
Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Marcelo Westerlund Montera, Fabiana G Marcondes-Braga, Marcus Vinícius Simões

|Sep 06, 2018
CCR5del32 genotype in human enteroviral cardiomyopathy leads to spontaneous virus clearance and improved outcome compared to wildtype CCR5.

Dirk Lassner, Christine S Siegismund, Uwe Kühl

Pageof 1